Show simple item record

dc.contributor.authorCipriani, Andrea
dc.contributor.authorCowen, Philip J
dc.date.accessioned2018-10-23T11:48:02Z
dc.date.available2018-10-23T11:48:02Z
dc.date.issued2018-06
dc.identifier.citationCipriani, Andrea and Cowen, Philip J. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. Lancet Psychiatry 2018-06-01, Volume 5, Issue 6, Pages 453-455en
dc.identifier.issn2215-0374
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/115
dc.descriptionPublished online at: https://doi.org/10.1016/S2215-0366(18)30170-6 Eligible users can access the full text via NHS OpenAthens at [https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2215036618301706] (login required).en
dc.description.abstractComment: This current study describes the therapeutic use of MDMA by committed experts in a specialised setting in a small group of participants, most of whom self-referred for the trial. The unmet need for better PTSD treatment, particularly in veterans and first responders, is undoubted. However, the generalisability of the benefit of MDMA-assisted psychotherapy to more mainstream psychiatry remains to be established, recalling perhaps the famous American watchword, “Will it play in Peoria?”en
dc.language.isoenen
dc.subjectVeteransen
dc.subjectPost-Traumatic Stress Disorder (PTSD)en
dc.subjectFirst Responders
dc.title3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnelen
dc.typeArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record